Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$17,108,670
+$3,851,106 QoQ
Shares Held
14,264
-1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.30%
of 13F equity value
Holder Rank
#969
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHEETS SMITH WEALTH MANAGEMENT holds $34,544,473 across 9 Drug Manufacturers - General names. LLY ranks #1 (49.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,264 | $17,108,670 | |
| 2 | AMGN |
Amgen Inc
|
17,231 | $6,239,689 | |
| 3 | ABBV |
AbbVie Inc.
|
14,811 | $3,727,040 | |
| 4 | JNJ |
Johnson & Johnson
|
11,131 | $2,826,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,343 | $2,742,575 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,247 | $915,585 | |
| 7 | NVS |
Novartis AG
|
2,450 | $383,964 | |
| 8 | PFE |
Pfizer Inc
|
14,609 | $351,784 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,108,670 | 14,264 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $13,257,564 | 14,414 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $16,122,350 | 15,002 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $11,004,749 | 14,423 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $11,058,412 | 14,186 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $11,697,363 | 14,163 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $10,748,556 | 13,923 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $11,574,806 | 13,065 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $7,961,911 | 8,794 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,752,743 | 2,253 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,333,138 | 2,287 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,225,730 | 2,282 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,069,743 | 2,281 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $795,704 | 2,317 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $843,992 | 2,307 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $784,770 | 2,427 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $783,339 | 2,416 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $687,574 | 2,401 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $662,651 | 2,399 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $554,057 | 2,398 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $550,388 | 2,398 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $447,807 | 2,397 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $423,281 | 2,507 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $863,400 | 5,833 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $411,435 | 2,506 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $347,493 | 2,505 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||